| Title |
Pharmacological interventions for those who have sexually offended or are at risk of offending
|
|---|---|
| Published in |
Cochrane database of systematic reviews, February 2015
|
| DOI | 10.1002/14651858.cd007989.pub2 |
| Pubmed ID | |
| Authors |
Omer Khan, Michael Ferriter, Nick Huband, Melanie J Powney, Jane A Dennis, Conor Duggan |
| Abstract |
Sexual offending is a serious social problem, a public health issue, and a major challenge for social policy. Victim surveys indicate high incidence and prevalence levels and it is accepted that there is a high proportion of hidden sexual victimisation. Surveys report high levels of psychiatric morbidity in survivors of sexual offences.Biological treatments of sex offenders include antilibidinal medication, comprising hormonal drugs that have a testosterone-suppressing effect, and non-hormonal drugs that affect libido through other mechanisms. The three main classes of testosterone-suppressing drugs in current use are progestogens, antiandrogens, and gonadotropin-releasing hormone (GnRH) analogues. Medications that affect libido through other means include antipsychotics and serotonergic antidepressants (SSRIs). |
X Demographics
The data shown below were collected from the profiles of 40 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 4 | 10% |
| United States | 4 | 10% |
| Sweden | 3 | 8% |
| Spain | 2 | 5% |
| Japan | 2 | 5% |
| Pakistan | 1 | 3% |
| Switzerland | 1 | 3% |
| Ecuador | 1 | 3% |
| Germany | 1 | 3% |
| Other | 2 | 5% |
| Unknown | 19 | 48% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 33 | 83% |
| Practitioners (doctors, other healthcare professionals) | 4 | 10% |
| Scientists | 3 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 821 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 819 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 111 | 14% |
| Student > Ph. D. Student | 100 | 12% |
| Student > Bachelor | 97 | 12% |
| Researcher | 94 | 11% |
| Student > Doctoral Student | 59 | 7% |
| Other | 143 | 17% |
| Unknown | 217 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 181 | 22% |
| Psychology | 157 | 19% |
| Nursing and Health Professions | 85 | 10% |
| Social Sciences | 52 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 2% |
| Other | 85 | 10% |
| Unknown | 245 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2024.
All research outputs
#1,083,133
of 25,698,912 outputs
Outputs from Cochrane database of systematic reviews
#2,172
of 13,136 outputs
Outputs of similar age
#13,139
of 269,806 outputs
Outputs of similar age from Cochrane database of systematic reviews
#48
of 286 outputs
Altmetric has tracked 25,698,912 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,136 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 269,806 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 286 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.